Cena s DPH / bez DPH
Hlavní stránka>ISO/TS 7552-2:2024-Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood — Part 2: Isolated DNA
sklademVydáno: 2024
ISO/TS 7552-2:2024-Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood — Part 2: Isolated DNA

ISO/TS 7552-2:2024

ISO/TS 7552-2:2024-Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood — Part 2: Isolated DNA

Formát
Dostupnost
Cena a měna
Anglicky PDF
K okamžitému stažení
3990 Kč
Anglicky Tisk
Skladem
3990 Kč
Označení normy:ISO/TS 7552-2:2024
Počet stran:19
Vydání:1
Vydáno:2024
Jazyk:Anglicky
Počet stran (Anglicky):19
Popis

ISO/TS 7552-2:2024


This document specifies requirements and gives recommendations on the handling, storage, CTC enrichment and isolation, DNA isolation and storage, and documentation of venous whole blood specimens intended for the examination of DNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research, and regulatory authorities. This document does not cover the isolation of genomic DNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-2. This document does not cover the isolation of specific white blood cells and subsequent isolation of genomic DNA therefrom or the pre-analytical workflow requirements for viable CTC cryopreservation and culturing. NOTE 1        The requirements given in this document can also be applied to other circulating rare cells (e.g. foetal cells). NOTE 2        International, national, or regional regulations or requirements can also apply to specific topics covered in this document.